RxDoctor Payments Data

Kimberly Benish, APRN

Family · Prescott, ARNPI 1104000553

Payments from drug & device makers

$723in general payments, 2019–2025

Across 47 payments — averaging $15.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$265
  • Lilly USA, LLC$136
  • Pfizer$60
  • Bayer$54
  • Boehringer Ingelheim$53
  • AbbVie$40
  • plus $115 from 5 others

What the payments were for

  • Food & beverage$723100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$723 in reported general payments places this provider in the 60th percentile of 2,103 family providers in Arkansas.

See all family providers in Arkansas

Medicare billing

Part B allowed, 2024
$26,021
Medicare patients
69
Services billed
639

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide45$52,794
Trelegy ElliptaFluticasone/Umeclidin/Vilanter38$37,639
EntrestoSacubitril/Valsartan28$29,665
MounjaroTirzepatide13$22,784
EliquisApixaban26$19,700
LinzessLinaclotide11$15,313
JardianceEmpagliflozin12$8,188
Tresiba Flextouch U-100Insulin Degludec12$5,760
Albuterol Sulfate HfaAlbuterol Sulfate34$1,160
Losartan Potassium100$912
Potassium Chloride52$832
Memantine Hcl29$795
Pantoprazole Sodium46$689
Ropinirole Hcl24$664
Ipratropium Bromide25$655

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$38$52,79445 claims
GSKTrelegy Ellipta$265$37,63938 claims
Lilly USA, LLCMounjaro$136$22,78413 claims
PfizerEliquis$60$19,70026 claims
AbbVieLinzess$40$15,31311 claims
Boehringer IngelheimJardiance$53$8,18812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,103 family providers in Arkansas.

Other family in Prescott

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →